Quipt Home Medical Corp.
Quipt Home Medical Corp. (QIPT) Stock Competitors & Peer Comparison
See (QIPT) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Devices Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| QIPT | $2.31 | +4.52% | 100.4M | -11.00 | -$0.21 | N/A |
| ABT | $127.29 | +0.87% | 221.5B | 15.95 | $7.98 | +1.82% |
| BSX-PA | $122.18 | +2.37% | 175.4B | 230.53 | $0.53 | N/A |
| BSX | $105.41 | +0.47% | 155.9B | 62.73 | $1.68 | N/A |
| SYK | $377.79 | -3.80% | 144.5B | 50.13 | $7.54 | +0.88% |
| MDT | $89.34 | -1.00% | 114.4B | 24.74 | $3.61 | +3.15% |
| EW | $79.33 | +0.03% | 46.5B | 33.19 | $2.39 | N/A |
| DXCM | $79.28 | -1.84% | 31.1B | 55.83 | $1.42 | N/A |
| PHG | $26.46 | +0.99% | 25.1B | 146.92 | $0.18 | +3.36% |
| STE | $226.87 | +0.17% | 22.3B | 36.84 | $6.16 | +1.01% |
Stock Comparison
QIPT vs ABT Comparison August 2025
QIPT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QIPT stands at 100.4M. In comparison, ABT has a market cap of 221.5B. Regarding current trading prices, QIPT is priced at $2.31, while ABT trades at $127.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QIPT currently has a P/E ratio of -11.00, whereas ABT's P/E ratio is 15.95. In terms of profitability, QIPT's ROE is -0.08%, compared to ABT's ROE of +0.32%. Regarding short-term risk, QIPT is more volatile compared to ABT. This indicates potentially higher risk in terms of short-term price fluctuations for QIPT.Check ABT's competition here
QIPT vs BSX-PA Comparison August 2025
QIPT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QIPT stands at 100.4M. In comparison, BSX-PA has a market cap of 175.4B. Regarding current trading prices, QIPT is priced at $2.31, while BSX-PA trades at $122.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QIPT currently has a P/E ratio of -11.00, whereas BSX-PA's P/E ratio is 230.53. In terms of profitability, QIPT's ROE is -0.08%, compared to BSX-PA's ROE of +0.12%. Regarding short-term risk, QIPT is more volatile compared to BSX-PA. This indicates potentially higher risk in terms of short-term price fluctuations for QIPT.Check BSX-PA's competition here
QIPT vs BSX Comparison August 2025
QIPT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QIPT stands at 100.4M. In comparison, BSX has a market cap of 155.9B. Regarding current trading prices, QIPT is priced at $2.31, while BSX trades at $105.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QIPT currently has a P/E ratio of -11.00, whereas BSX's P/E ratio is 62.73. In terms of profitability, QIPT's ROE is -0.08%, compared to BSX's ROE of +0.12%. Regarding short-term risk, QIPT is more volatile compared to BSX. This indicates potentially higher risk in terms of short-term price fluctuations for QIPT.Check BSX's competition here
QIPT vs SYK Comparison August 2025
QIPT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QIPT stands at 100.4M. In comparison, SYK has a market cap of 144.5B. Regarding current trading prices, QIPT is priced at $2.31, while SYK trades at $377.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QIPT currently has a P/E ratio of -11.00, whereas SYK's P/E ratio is 50.13. In terms of profitability, QIPT's ROE is -0.08%, compared to SYK's ROE of +0.11%. Regarding short-term risk, QIPT is more volatile compared to SYK. This indicates potentially higher risk in terms of short-term price fluctuations for QIPT.Check SYK's competition here
QIPT vs MDT Comparison August 2025
QIPT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QIPT stands at 100.4M. In comparison, MDT has a market cap of 114.4B. Regarding current trading prices, QIPT is priced at $2.31, while MDT trades at $89.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QIPT currently has a P/E ratio of -11.00, whereas MDT's P/E ratio is 24.74. In terms of profitability, QIPT's ROE is -0.08%, compared to MDT's ROE of +0.10%. Regarding short-term risk, QIPT is more volatile compared to MDT. This indicates potentially higher risk in terms of short-term price fluctuations for QIPT.Check MDT's competition here
QIPT vs EW Comparison August 2025
QIPT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QIPT stands at 100.4M. In comparison, EW has a market cap of 46.5B. Regarding current trading prices, QIPT is priced at $2.31, while EW trades at $79.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QIPT currently has a P/E ratio of -11.00, whereas EW's P/E ratio is 33.19. In terms of profitability, QIPT's ROE is -0.08%, compared to EW's ROE of +0.45%. Regarding short-term risk, QIPT is more volatile compared to EW. This indicates potentially higher risk in terms of short-term price fluctuations for QIPT.Check EW's competition here
QIPT vs DXCM Comparison August 2025
QIPT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QIPT stands at 100.4M. In comparison, DXCM has a market cap of 31.1B. Regarding current trading prices, QIPT is priced at $2.31, while DXCM trades at $79.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QIPT currently has a P/E ratio of -11.00, whereas DXCM's P/E ratio is 55.83. In terms of profitability, QIPT's ROE is -0.08%, compared to DXCM's ROE of +0.26%. Regarding short-term risk, QIPT is more volatile compared to DXCM. This indicates potentially higher risk in terms of short-term price fluctuations for QIPT.Check DXCM's competition here
QIPT vs PHG Comparison August 2025
QIPT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QIPT stands at 100.4M. In comparison, PHG has a market cap of 25.1B. Regarding current trading prices, QIPT is priced at $2.31, while PHG trades at $26.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QIPT currently has a P/E ratio of -11.00, whereas PHG's P/E ratio is 146.92. In terms of profitability, QIPT's ROE is -0.08%, compared to PHG's ROE of +0.03%. Regarding short-term risk, QIPT is more volatile compared to PHG. This indicates potentially higher risk in terms of short-term price fluctuations for QIPT.Check PHG's competition here
QIPT vs STE Comparison August 2025
QIPT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QIPT stands at 100.4M. In comparison, STE has a market cap of 22.3B. Regarding current trading prices, QIPT is priced at $2.31, while STE trades at $226.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QIPT currently has a P/E ratio of -11.00, whereas STE's P/E ratio is 36.84. In terms of profitability, QIPT's ROE is -0.08%, compared to STE's ROE of +0.09%. Regarding short-term risk, QIPT is more volatile compared to STE. This indicates potentially higher risk in terms of short-term price fluctuations for QIPT.Check STE's competition here
QIPT vs PODD Comparison August 2025
QIPT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QIPT stands at 100.4M. In comparison, PODD has a market cap of 20.1B. Regarding current trading prices, QIPT is priced at $2.31, while PODD trades at $284.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QIPT currently has a P/E ratio of -11.00, whereas PODD's P/E ratio is 51.34. In terms of profitability, QIPT's ROE is -0.08%, compared to PODD's ROE of +0.35%. Regarding short-term risk, QIPT is more volatile compared to PODD. This indicates potentially higher risk in terms of short-term price fluctuations for QIPT.Check PODD's competition here
QIPT vs ZBH Comparison August 2025
QIPT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QIPT stands at 100.4M. In comparison, ZBH has a market cap of 17.9B. Regarding current trading prices, QIPT is priced at $2.31, while ZBH trades at $90.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QIPT currently has a P/E ratio of -11.00, whereas ZBH's P/E ratio is 20.13. In terms of profitability, QIPT's ROE is -0.08%, compared to ZBH's ROE of +0.07%. Regarding short-term risk, QIPT is more volatile compared to ZBH. This indicates potentially higher risk in terms of short-term price fluctuations for QIPT.Check ZBH's competition here
QIPT vs ABMD Comparison August 2025
QIPT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QIPT stands at 100.4M. In comparison, ABMD has a market cap of 17.2B. Regarding current trading prices, QIPT is priced at $2.31, while ABMD trades at $381.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QIPT currently has a P/E ratio of -11.00, whereas ABMD's P/E ratio is 65.36. In terms of profitability, QIPT's ROE is -0.08%, compared to ABMD's ROE of +0.10%. Regarding short-term risk, QIPT is more volatile compared to ABMD. This indicates potentially higher risk in terms of short-term price fluctuations for QIPT.Check ABMD's competition here
QIPT vs SNN Comparison August 2025
QIPT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QIPT stands at 100.4M. In comparison, SNN has a market cap of 13.5B. Regarding current trading prices, QIPT is priced at $2.31, while SNN trades at $30.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QIPT currently has a P/E ratio of -11.00, whereas SNN's P/E ratio is 32.82. In terms of profitability, QIPT's ROE is -0.08%, compared to SNN's ROE of +0.08%. Regarding short-term risk, QIPT is more volatile compared to SNN. This indicates potentially higher risk in terms of short-term price fluctuations for QIPT.Check SNN's competition here
QIPT vs SWAV Comparison August 2025
QIPT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QIPT stands at 100.4M. In comparison, SWAV has a market cap of 12.6B. Regarding current trading prices, QIPT is priced at $2.31, while SWAV trades at $334.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QIPT currently has a P/E ratio of -11.00, whereas SWAV's P/E ratio is 78.76. In terms of profitability, QIPT's ROE is -0.08%, compared to SWAV's ROE of +0.14%. Regarding short-term risk, QIPT is more volatile compared to SWAV. This indicates potentially higher risk in terms of short-term price fluctuations for QIPT.Check SWAV's competition here
QIPT vs ALGN Comparison August 2025
QIPT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QIPT stands at 100.4M. In comparison, ALGN has a market cap of 9.9B. Regarding current trading prices, QIPT is priced at $2.31, while ALGN trades at $136.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QIPT currently has a P/E ratio of -11.00, whereas ALGN's P/E ratio is 23.06. In terms of profitability, QIPT's ROE is -0.08%, compared to ALGN's ROE of +0.11%. Regarding short-term risk, QIPT is more volatile compared to ALGN. This indicates potentially higher risk in terms of short-term price fluctuations for QIPT.Check ALGN's competition here
QIPT vs PEN Comparison August 2025
QIPT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QIPT stands at 100.4M. In comparison, PEN has a market cap of 9.5B. Regarding current trading prices, QIPT is priced at $2.31, while PEN trades at $243.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QIPT currently has a P/E ratio of -11.00, whereas PEN's P/E ratio is 64.08. In terms of profitability, QIPT's ROE is -0.08%, compared to PEN's ROE of +0.12%. Regarding short-term risk, QIPT is more volatile compared to PEN. This indicates potentially higher risk in terms of short-term price fluctuations for QIPT.Check PEN's competition here
QIPT vs BIO Comparison August 2025
QIPT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QIPT stands at 100.4M. In comparison, BIO has a market cap of 7.8B. Regarding current trading prices, QIPT is priced at $2.31, while BIO trades at $284.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QIPT currently has a P/E ratio of -11.00, whereas BIO's P/E ratio is -3.72. In terms of profitability, QIPT's ROE is -0.08%, compared to BIO's ROE of +0.05%. Regarding short-term risk, QIPT is more volatile compared to BIO. This indicates potentially higher risk in terms of short-term price fluctuations for QIPT.Check BIO's competition here
QIPT vs GMED Comparison August 2025
QIPT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QIPT stands at 100.4M. In comparison, GMED has a market cap of 7.1B. Regarding current trading prices, QIPT is priced at $2.31, while GMED trades at $52.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QIPT currently has a P/E ratio of -11.00, whereas GMED's P/E ratio is 39.28. In terms of profitability, QIPT's ROE is -0.08%, compared to GMED's ROE of +0.05%. Regarding short-term risk, QIPT is more volatile compared to GMED. This indicates potentially higher risk in terms of short-term price fluctuations for QIPT.Check GMED's competition here
QIPT vs BIO-B Comparison August 2025
QIPT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QIPT stands at 100.4M. In comparison, BIO-B has a market cap of 6.8B. Regarding current trading prices, QIPT is priced at $2.31, while BIO-B trades at $247.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QIPT currently has a P/E ratio of -11.00, whereas BIO-B's P/E ratio is -3.23. In terms of profitability, QIPT's ROE is -0.08%, compared to BIO-B's ROE of +0.05%. Regarding short-term risk, QIPT is more volatile compared to BIO-B. This indicates potentially higher risk in terms of short-term price fluctuations for QIPT.Check BIO-B's competition here
QIPT vs BRKR Comparison August 2025
QIPT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QIPT stands at 100.4M. In comparison, BRKR has a market cap of 5.8B. Regarding current trading prices, QIPT is priced at $2.31, while BRKR trades at $37.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QIPT currently has a P/E ratio of -11.00, whereas BRKR's P/E ratio is 73.02. In terms of profitability, QIPT's ROE is -0.08%, compared to BRKR's ROE of +0.04%. Regarding short-term risk, QIPT is more volatile compared to BRKR. This indicates potentially higher risk in terms of short-term price fluctuations for QIPT.Check BRKR's competition here
QIPT vs IRTC Comparison August 2025
QIPT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QIPT stands at 100.4M. In comparison, IRTC has a market cap of 5.3B. Regarding current trading prices, QIPT is priced at $2.31, while IRTC trades at $164.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QIPT currently has a P/E ratio of -11.00, whereas IRTC's P/E ratio is -52.71. In terms of profitability, QIPT's ROE is -0.08%, compared to IRTC's ROE of -1.05%. Regarding short-term risk, QIPT is less volatile compared to IRTC. This indicates potentially lower risk in terms of short-term price fluctuations for QIPT.Check IRTC's competition here
QIPT vs GKOS Comparison August 2025
QIPT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QIPT stands at 100.4M. In comparison, GKOS has a market cap of 4.9B. Regarding current trading prices, QIPT is priced at $2.31, while GKOS trades at $86.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QIPT currently has a P/E ratio of -11.00, whereas GKOS's P/E ratio is -53.51. In terms of profitability, QIPT's ROE is -0.08%, compared to GKOS's ROE of -0.13%. Regarding short-term risk, QIPT is more volatile compared to GKOS. This indicates potentially higher risk in terms of short-term price fluctuations for QIPT.Check GKOS's competition here
QIPT vs NARI Comparison August 2025
QIPT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QIPT stands at 100.4M. In comparison, NARI has a market cap of 4.7B. Regarding current trading prices, QIPT is priced at $2.31, while NARI trades at $79.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QIPT currently has a P/E ratio of -11.00, whereas NARI's P/E ratio is -59.24. In terms of profitability, QIPT's ROE is -0.08%, compared to NARI's ROE of -0.18%. Regarding short-term risk, QIPT is more volatile compared to NARI. This indicates potentially higher risk in terms of short-term price fluctuations for QIPT.Check NARI's competition here
QIPT vs TMDX Comparison August 2025
QIPT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QIPT stands at 100.4M. In comparison, TMDX has a market cap of 4.1B. Regarding current trading prices, QIPT is priced at $2.31, while TMDX trades at $120.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QIPT currently has a P/E ratio of -11.00, whereas TMDX's P/E ratio is 60.58. In terms of profitability, QIPT's ROE is -0.08%, compared to TMDX's ROE of +0.28%. Regarding short-term risk, QIPT is more volatile compared to TMDX. This indicates potentially higher risk in terms of short-term price fluctuations for QIPT.Check TMDX's competition here
QIPT vs ITGR Comparison August 2025
QIPT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QIPT stands at 100.4M. In comparison, ITGR has a market cap of 3.7B. Regarding current trading prices, QIPT is priced at $2.31, while ITGR trades at $106.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QIPT currently has a P/E ratio of -11.00, whereas ITGR's P/E ratio is 45.47. In terms of profitability, QIPT's ROE is -0.08%, compared to ITGR's ROE of +0.05%. Regarding short-term risk, QIPT is more volatile compared to ITGR. This indicates potentially higher risk in terms of short-term price fluctuations for QIPT.Check ITGR's competition here
QIPT vs INSP Comparison August 2025
QIPT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QIPT stands at 100.4M. In comparison, INSP has a market cap of 3.7B. Regarding current trading prices, QIPT is priced at $2.31, while INSP trades at $126.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QIPT currently has a P/E ratio of -11.00, whereas INSP's P/E ratio is 57.54. In terms of profitability, QIPT's ROE is -0.08%, compared to INSP's ROE of +0.10%. Regarding short-term risk, QIPT is more volatile compared to INSP. This indicates potentially higher risk in terms of short-term price fluctuations for QIPT.Check INSP's competition here
QIPT vs AXNX Comparison August 2025
QIPT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QIPT stands at 100.4M. In comparison, AXNX has a market cap of 3.6B. Regarding current trading prices, QIPT is priced at $2.31, while AXNX trades at $70.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QIPT currently has a P/E ratio of -11.00, whereas AXNX's P/E ratio is -709.80. In terms of profitability, QIPT's ROE is -0.08%, compared to AXNX's ROE of -0.01%. Regarding short-term risk, QIPT is more volatile compared to AXNX. This indicates potentially higher risk in terms of short-term price fluctuations for QIPT.Check AXNX's competition here
QIPT vs PRCT Comparison August 2025
QIPT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QIPT stands at 100.4M. In comparison, PRCT has a market cap of 2.8B. Regarding current trading prices, QIPT is priced at $2.31, while PRCT trades at $49.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QIPT currently has a P/E ratio of -11.00, whereas PRCT's P/E ratio is -29.56. In terms of profitability, QIPT's ROE is -0.08%, compared to PRCT's ROE of -0.28%. Regarding short-term risk, QIPT is more volatile compared to PRCT. This indicates potentially higher risk in terms of short-term price fluctuations for QIPT.Check PRCT's competition here
QIPT vs LIVN Comparison August 2025
QIPT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QIPT stands at 100.4M. In comparison, LIVN has a market cap of 2.2B. Regarding current trading prices, QIPT is priced at $2.31, while LIVN trades at $41.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QIPT currently has a P/E ratio of -11.00, whereas LIVN's P/E ratio is -10.11. In terms of profitability, QIPT's ROE is -0.08%, compared to LIVN's ROE of -0.18%. Regarding short-term risk, QIPT is more volatile compared to LIVN. This indicates potentially higher risk in terms of short-term price fluctuations for QIPT.Check LIVN's competition here
QIPT vs NUVA Comparison August 2025
QIPT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QIPT stands at 100.4M. In comparison, NUVA has a market cap of 2.1B. Regarding current trading prices, QIPT is priced at $2.31, while NUVA trades at $39.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QIPT currently has a P/E ratio of -11.00, whereas NUVA's P/E ratio is 75.00. In terms of profitability, QIPT's ROE is -0.08%, compared to NUVA's ROE of +0.05%. Regarding short-term risk, QIPT is more volatile compared to NUVA. This indicates potentially higher risk in terms of short-term price fluctuations for QIPT.Check NUVA's competition here
QIPT vs ATEC Comparison August 2025
QIPT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QIPT stands at 100.4M. In comparison, ATEC has a market cap of 2B. Regarding current trading prices, QIPT is priced at $2.31, while ATEC trades at $13.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QIPT currently has a P/E ratio of -11.00, whereas ATEC's P/E ratio is -12.08. In terms of profitability, QIPT's ROE is -0.08%, compared to ATEC's ROE of -2.77%. Regarding short-term risk, QIPT is less volatile compared to ATEC. This indicates potentially lower risk in terms of short-term price fluctuations for QIPT.Check ATEC's competition here
QIPT vs UFPT Comparison August 2025
QIPT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QIPT stands at 100.4M. In comparison, UFPT has a market cap of 1.7B. Regarding current trading prices, QIPT is priced at $2.31, while UFPT trades at $226.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QIPT currently has a P/E ratio of -11.00, whereas UFPT's P/E ratio is 27.80. In terms of profitability, QIPT's ROE is -0.08%, compared to UFPT's ROE of +0.19%. Regarding short-term risk, QIPT is more volatile compared to UFPT. This indicates potentially higher risk in terms of short-term price fluctuations for QIPT.Check UFPT's competition here
QIPT vs CNMD Comparison August 2025
QIPT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QIPT stands at 100.4M. In comparison, CNMD has a market cap of 1.6B. Regarding current trading prices, QIPT is priced at $2.31, while CNMD trades at $52.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QIPT currently has a P/E ratio of -11.00, whereas CNMD's P/E ratio is 14.78. In terms of profitability, QIPT's ROE is -0.08%, compared to CNMD's ROE of +0.11%. Regarding short-term risk, QIPT is more volatile compared to CNMD. This indicates potentially higher risk in terms of short-term price fluctuations for QIPT.Check CNMD's competition here
QIPT vs AORT Comparison August 2025
QIPT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QIPT stands at 100.4M. In comparison, AORT has a market cap of 1.3B. Regarding current trading prices, QIPT is priced at $2.31, while AORT trades at $30.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QIPT currently has a P/E ratio of -11.00, whereas AORT's P/E ratio is -60.67. In terms of profitability, QIPT's ROE is -0.08%, compared to AORT's ROE of -0.07%. Regarding short-term risk, QIPT is more volatile compared to AORT. This indicates potentially higher risk in terms of short-term price fluctuations for QIPT.Check AORT's competition here
QIPT vs HSKA Comparison August 2025
QIPT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QIPT stands at 100.4M. In comparison, HSKA has a market cap of 1.3B. Regarding current trading prices, QIPT is priced at $2.31, while HSKA trades at $119.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QIPT currently has a P/E ratio of -11.00, whereas HSKA's P/E ratio is -62.49. In terms of profitability, QIPT's ROE is -0.08%, compared to HSKA's ROE of -0.04%. Regarding short-term risk, QIPT is more volatile compared to HSKA. This indicates potentially higher risk in terms of short-term price fluctuations for QIPT.Check HSKA's competition here
QIPT vs SSII Comparison August 2025
QIPT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QIPT stands at 100.4M. In comparison, SSII has a market cap of 1.2B. Regarding current trading prices, QIPT is priced at $2.31, while SSII trades at $6.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QIPT currently has a P/E ratio of -11.00, whereas SSII's P/E ratio is -77.50. In terms of profitability, QIPT's ROE is -0.08%, compared to SSII's ROE of -1.05%. Regarding short-term risk, QIPT is less volatile compared to SSII. This indicates potentially lower risk in terms of short-term price fluctuations for QIPT.Check SSII's competition here
QIPT vs ESTA Comparison August 2025
QIPT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QIPT stands at 100.4M. In comparison, ESTA has a market cap of 1.2B. Regarding current trading prices, QIPT is priced at $2.31, while ESTA trades at $41.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QIPT currently has a P/E ratio of -11.00, whereas ESTA's P/E ratio is -13.25. In terms of profitability, QIPT's ROE is -0.08%, compared to ESTA's ROE of -2.10%. Regarding short-term risk, QIPT is more volatile compared to ESTA. This indicates potentially higher risk in terms of short-term price fluctuations for QIPT.Check ESTA's competition here
QIPT vs AHCO Comparison August 2025
QIPT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QIPT stands at 100.4M. In comparison, AHCO has a market cap of 1.2B. Regarding current trading prices, QIPT is priced at $2.31, while AHCO trades at $8.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QIPT currently has a P/E ratio of -11.00, whereas AHCO's P/E ratio is 15.09. In terms of profitability, QIPT's ROE is -0.08%, compared to AHCO's ROE of +0.06%. Regarding short-term risk, QIPT is more volatile compared to AHCO. This indicates potentially higher risk in terms of short-term price fluctuations for QIPT.Check AHCO's competition here
QIPT vs SILK Comparison August 2025
QIPT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QIPT stands at 100.4M. In comparison, SILK has a market cap of 1.1B. Regarding current trading prices, QIPT is priced at $2.31, while SILK trades at $27.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QIPT currently has a P/E ratio of -11.00, whereas SILK's P/E ratio is -18.96. In terms of profitability, QIPT's ROE is -0.08%, compared to SILK's ROE of -0.29%. Regarding short-term risk, QIPT is more volatile compared to SILK. This indicates potentially higher risk in terms of short-term price fluctuations for QIPT.Check SILK's competition here
QIPT vs FNA Comparison August 2025
QIPT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QIPT stands at 100.4M. In comparison, FNA has a market cap of 1.1B. Regarding current trading prices, QIPT is priced at $2.31, while FNA trades at $13.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QIPT currently has a P/E ratio of -11.00, whereas FNA's P/E ratio is -19.83. In terms of profitability, QIPT's ROE is -0.08%, compared to FNA's ROE of -0.36%. Regarding short-term risk, QIPT is more volatile compared to FNA. This indicates potentially higher risk in terms of short-term price fluctuations for QIPT.Check FNA's competition here
QIPT vs TNDM Comparison August 2025
QIPT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QIPT stands at 100.4M. In comparison, TNDM has a market cap of 1B. Regarding current trading prices, QIPT is priced at $2.31, while TNDM trades at $15.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QIPT currently has a P/E ratio of -11.00, whereas TNDM's P/E ratio is -5.52. In terms of profitability, QIPT's ROE is -0.08%, compared to TNDM's ROE of -0.83%. Regarding short-term risk, QIPT is more volatile compared to TNDM. This indicates potentially higher risk in terms of short-term price fluctuations for QIPT.Check TNDM's competition here
QIPT vs IART Comparison August 2025
QIPT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QIPT stands at 100.4M. In comparison, IART has a market cap of 956.6M. Regarding current trading prices, QIPT is priced at $2.31, while IART trades at $12.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QIPT currently has a P/E ratio of -11.00, whereas IART's P/E ratio is -1.88. In terms of profitability, QIPT's ROE is -0.08%, compared to IART's ROE of -0.44%. Regarding short-term risk, QIPT is more volatile compared to IART. This indicates potentially higher risk in terms of short-term price fluctuations for QIPT.Check IART's competition here
QIPT vs INMD Comparison August 2025
QIPT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QIPT stands at 100.4M. In comparison, INMD has a market cap of 955.7M. Regarding current trading prices, QIPT is priced at $2.31, while INMD trades at $13.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QIPT currently has a P/E ratio of -11.00, whereas INMD's P/E ratio is 5.77. In terms of profitability, QIPT's ROE is -0.08%, compared to INMD's ROE of +0.27%. Regarding short-term risk, QIPT is more volatile compared to INMD. This indicates potentially higher risk in terms of short-term price fluctuations for QIPT.Check INMD's competition here
QIPT vs CSII Comparison August 2025
QIPT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QIPT stands at 100.4M. In comparison, CSII has a market cap of 844M. Regarding current trading prices, QIPT is priced at $2.31, while CSII trades at $20.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QIPT currently has a P/E ratio of -11.00, whereas CSII's P/E ratio is -20.83. In terms of profitability, QIPT's ROE is -0.08%, compared to CSII's ROE of -0.14%. Regarding short-term risk, QIPT is more volatile compared to CSII. This indicates potentially higher risk in terms of short-term price fluctuations for QIPT.Check CSII's competition here
QIPT vs IRMD Comparison August 2025
QIPT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QIPT stands at 100.4M. In comparison, IRMD has a market cap of 841.4M. Regarding current trading prices, QIPT is priced at $2.31, while IRMD trades at $66.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QIPT currently has a P/E ratio of -11.00, whereas IRMD's P/E ratio is 42.69. In terms of profitability, QIPT's ROE is -0.08%, compared to IRMD's ROE of +0.23%. Regarding short-term risk, QIPT is less volatile compared to IRMD. This indicates potentially lower risk in terms of short-term price fluctuations for QIPT.Check IRMD's competition here
QIPT vs SMLR Comparison August 2025
QIPT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QIPT stands at 100.4M. In comparison, SMLR has a market cap of 799M. Regarding current trading prices, QIPT is priced at $2.31, while SMLR trades at $34.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QIPT currently has a P/E ratio of -11.00, whereas SMLR's P/E ratio is -14.42. In terms of profitability, QIPT's ROE is -0.08%, compared to SMLR's ROE of -0.21%. Regarding short-term risk, QIPT is more volatile compared to SMLR. This indicates potentially higher risk in terms of short-term price fluctuations for QIPT.Check SMLR's competition here
QIPT vs SIBN Comparison August 2025
QIPT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QIPT stands at 100.4M. In comparison, SIBN has a market cap of 741.1M. Regarding current trading prices, QIPT is priced at $2.31, while SIBN trades at $17.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QIPT currently has a P/E ratio of -11.00, whereas SIBN's P/E ratio is -27.60. In terms of profitability, QIPT's ROE is -0.08%, compared to SIBN's ROE of -0.16%. Regarding short-term risk, QIPT is more volatile compared to SIBN. This indicates potentially higher risk in terms of short-term price fluctuations for QIPT.Check SIBN's competition here
QIPT vs CRY Comparison August 2025
QIPT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QIPT stands at 100.4M. In comparison, CRY has a market cap of 725.1M. Regarding current trading prices, QIPT is priced at $2.31, while CRY trades at $17.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QIPT currently has a P/E ratio of -11.00, whereas CRY's P/E ratio is 425.71. In terms of profitability, QIPT's ROE is -0.08%, compared to CRY's ROE of -0.07%. Regarding short-term risk, QIPT is more volatile compared to CRY. This indicates potentially higher risk in terms of short-term price fluctuations for QIPT.Check CRY's competition here
QIPT vs APEN Comparison August 2025
QIPT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QIPT stands at 100.4M. In comparison, APEN has a market cap of 579.7M. Regarding current trading prices, QIPT is priced at $2.31, while APEN trades at $10.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QIPT currently has a P/E ratio of -11.00, whereas APEN's P/E ratio is -9.43. In terms of profitability, QIPT's ROE is -0.08%, compared to APEN's ROE of -0.85%. Regarding short-term risk, QIPT is more volatile compared to APEN. This indicates potentially higher risk in terms of short-term price fluctuations for QIPT.Check APEN's competition here
QIPT vs AXGN Comparison August 2025
QIPT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QIPT stands at 100.4M. In comparison, AXGN has a market cap of 577M. Regarding current trading prices, QIPT is priced at $2.31, while AXGN trades at $12.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QIPT currently has a P/E ratio of -11.00, whereas AXGN's P/E ratio is -79.19. In terms of profitability, QIPT's ROE is -0.08%, compared to AXGN's ROE of -0.07%. Regarding short-term risk, QIPT is more volatile compared to AXGN. This indicates potentially higher risk in terms of short-term price fluctuations for QIPT.Check AXGN's competition here
QIPT vs ZIMV Comparison August 2025
QIPT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QIPT stands at 100.4M. In comparison, ZIMV has a market cap of 529M. Regarding current trading prices, QIPT is priced at $2.31, while ZIMV trades at $18.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QIPT currently has a P/E ratio of -11.00, whereas ZIMV's P/E ratio is -20.84. In terms of profitability, QIPT's ROE is -0.08%, compared to ZIMV's ROE of -0.04%. Regarding short-term risk, QIPT is more volatile compared to ZIMV. This indicates potentially higher risk in terms of short-term price fluctuations for QIPT.Check ZIMV's competition here
QIPT vs SRDX Comparison August 2025
QIPT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QIPT stands at 100.4M. In comparison, SRDX has a market cap of 515.2M. Regarding current trading prices, QIPT is priced at $2.31, while SRDX trades at $36.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QIPT currently has a P/E ratio of -11.00, whereas SRDX's P/E ratio is -25.74. In terms of profitability, QIPT's ROE is -0.08%, compared to SRDX's ROE of -0.17%. Regarding short-term risk, QIPT is more volatile compared to SRDX. This indicates potentially higher risk in terms of short-term price fluctuations for QIPT.Check SRDX's competition here
QIPT vs CBLL Comparison August 2025
QIPT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QIPT stands at 100.4M. In comparison, CBLL has a market cap of 511.1M. Regarding current trading prices, QIPT is priced at $2.31, while CBLL trades at $14.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QIPT currently has a P/E ratio of -11.00, whereas CBLL's P/E ratio is -11.31. In terms of profitability, QIPT's ROE is -0.08%, compared to CBLL's ROE of -1.64%. Regarding short-term risk, QIPT is more volatile compared to CBLL. This indicates potentially higher risk in terms of short-term price fluctuations for QIPT.Check CBLL's competition here
QIPT vs AVNS Comparison August 2025
QIPT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QIPT stands at 100.4M. In comparison, AVNS has a market cap of 508.2M. Regarding current trading prices, QIPT is priced at $2.31, while AVNS trades at $10.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QIPT currently has a P/E ratio of -11.00, whereas AVNS's P/E ratio is -1.33. In terms of profitability, QIPT's ROE is -0.08%, compared to AVNS's ROE of -0.37%. Regarding short-term risk, QIPT is more volatile compared to AVNS. This indicates potentially higher risk in terms of short-term price fluctuations for QIPT.Check AVNS's competition here
QIPT vs KIDS Comparison August 2025
QIPT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QIPT stands at 100.4M. In comparison, KIDS has a market cap of 505M. Regarding current trading prices, QIPT is priced at $2.31, while KIDS trades at $20.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QIPT currently has a P/E ratio of -11.00, whereas KIDS's P/E ratio is -11.59. In terms of profitability, QIPT's ROE is -0.08%, compared to KIDS's ROE of -0.11%. Regarding short-term risk, QIPT is more volatile compared to KIDS. This indicates potentially higher risk in terms of short-term price fluctuations for QIPT.Check KIDS's competition here
QIPT vs CTKB Comparison August 2025
QIPT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QIPT stands at 100.4M. In comparison, CTKB has a market cap of 461M. Regarding current trading prices, QIPT is priced at $2.31, while CTKB trades at $3.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QIPT currently has a P/E ratio of -11.00, whereas CTKB's P/E ratio is -40.44. In terms of profitability, QIPT's ROE is -0.08%, compared to CTKB's ROE of -0.03%. Regarding short-term risk, QIPT is more volatile compared to CTKB. This indicates potentially higher risk in terms of short-term price fluctuations for QIPT.Check CTKB's competition here
QIPT vs OFIX Comparison August 2025
QIPT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QIPT stands at 100.4M. In comparison, OFIX has a market cap of 422M. Regarding current trading prices, QIPT is priced at $2.31, while OFIX trades at $10.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QIPT currently has a P/E ratio of -11.00, whereas OFIX's P/E ratio is -2.91. In terms of profitability, QIPT's ROE is -0.08%, compared to OFIX's ROE of -0.28%. Regarding short-term risk, QIPT is more volatile compared to OFIX. This indicates potentially higher risk in terms of short-term price fluctuations for QIPT.Check OFIX's competition here
QIPT vs BVS Comparison August 2025
QIPT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QIPT stands at 100.4M. In comparison, BVS has a market cap of 410.1M. Regarding current trading prices, QIPT is priced at $2.31, while BVS trades at $6.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QIPT currently has a P/E ratio of -11.00, whereas BVS's P/E ratio is -12.87. In terms of profitability, QIPT's ROE is -0.08%, compared to BVS's ROE of -0.21%. Regarding short-term risk, QIPT is more volatile compared to BVS. This indicates potentially higher risk in terms of short-term price fluctuations for QIPT.Check BVS's competition here
QIPT vs PACB Comparison August 2025
QIPT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QIPT stands at 100.4M. In comparison, PACB has a market cap of 399.1M. Regarding current trading prices, QIPT is priced at $2.31, while PACB trades at $1.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QIPT currently has a P/E ratio of -11.00, whereas PACB's P/E ratio is -0.49. In terms of profitability, QIPT's ROE is -0.08%, compared to PACB's ROE of -1.70%. Regarding short-term risk, QIPT is more volatile compared to PACB. This indicates potentially higher risk in terms of short-term price fluctuations for QIPT.Check PACB's competition here
QIPT vs SENS Comparison August 2025
QIPT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QIPT stands at 100.4M. In comparison, SENS has a market cap of 364.9M. Regarding current trading prices, QIPT is priced at $2.31, while SENS trades at $0.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QIPT currently has a P/E ratio of -11.00, whereas SENS's P/E ratio is -4.40. In terms of profitability, QIPT's ROE is -0.08%, compared to SENS's ROE of -7.46%. Regarding short-term risk, QIPT is more volatile compared to SENS. This indicates potentially higher risk in terms of short-term price fluctuations for QIPT.Check SENS's competition here
QIPT vs BFLY Comparison August 2025
QIPT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QIPT stands at 100.4M. In comparison, BFLY has a market cap of 346M. Regarding current trading prices, QIPT is priced at $2.31, while BFLY trades at $1.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QIPT currently has a P/E ratio of -11.00, whereas BFLY's P/E ratio is -4.66. In terms of profitability, QIPT's ROE is -0.08%, compared to BFLY's ROE of -0.31%. Regarding short-term risk, QIPT is less volatile compared to BFLY. This indicates potentially lower risk in terms of short-term price fluctuations for QIPT.Check BFLY's competition here
QIPT vs TMCI Comparison August 2025
QIPT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QIPT stands at 100.4M. In comparison, TMCI has a market cap of 335.9M. Regarding current trading prices, QIPT is priced at $2.31, while TMCI trades at $5.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QIPT currently has a P/E ratio of -11.00, whereas TMCI's P/E ratio is -6.28. In terms of profitability, QIPT's ROE is -0.08%, compared to TMCI's ROE of -0.49%. Regarding short-term risk, QIPT is more volatile compared to TMCI. This indicates potentially higher risk in terms of short-term price fluctuations for QIPT.Check TMCI's competition here
QIPT vs RXST Comparison August 2025
QIPT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QIPT stands at 100.4M. In comparison, RXST has a market cap of 317M. Regarding current trading prices, QIPT is priced at $2.31, while RXST trades at $7.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QIPT currently has a P/E ratio of -11.00, whereas RXST's P/E ratio is -11.82. In terms of profitability, QIPT's ROE is -0.08%, compared to RXST's ROE of -0.10%. Regarding short-term risk, QIPT is more volatile compared to RXST. This indicates potentially higher risk in terms of short-term price fluctuations for QIPT.Check RXST's competition here
QIPT vs SNWV Comparison August 2025
QIPT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QIPT stands at 100.4M. In comparison, SNWV has a market cap of 310.6M. Regarding current trading prices, QIPT is priced at $2.31, while SNWV trades at $36.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QIPT currently has a P/E ratio of -11.00, whereas SNWV's P/E ratio is -5.82. In terms of profitability, QIPT's ROE is -0.08%, compared to SNWV's ROE of +1.00%. Regarding short-term risk, QIPT is more volatile compared to SNWV. This indicates potentially higher risk in terms of short-term price fluctuations for QIPT.Check SNWV's competition here
QIPT vs VREX Comparison August 2025
QIPT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QIPT stands at 100.4M. In comparison, VREX has a market cap of 298M. Regarding current trading prices, QIPT is priced at $2.31, while VREX trades at $7.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QIPT currently has a P/E ratio of -11.00, whereas VREX's P/E ratio is -6.97. In terms of profitability, QIPT's ROE is -0.08%, compared to VREX's ROE of -0.08%. Regarding short-term risk, QIPT is more volatile compared to VREX. This indicates potentially higher risk in terms of short-term price fluctuations for QIPT.Check VREX's competition here
QIPT vs NPCE Comparison August 2025
QIPT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QIPT stands at 100.4M. In comparison, NPCE has a market cap of 294.9M. Regarding current trading prices, QIPT is priced at $2.31, while NPCE trades at $8.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QIPT currently has a P/E ratio of -11.00, whereas NPCE's P/E ratio is -10.96. In terms of profitability, QIPT's ROE is -0.08%, compared to NPCE's ROE of -1.40%. Regarding short-term risk, QIPT is more volatile compared to NPCE. This indicates potentially higher risk in terms of short-term price fluctuations for QIPT.Check NPCE's competition here
QIPT vs NNOX Comparison August 2025
QIPT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QIPT stands at 100.4M. In comparison, NNOX has a market cap of 293.3M. Regarding current trading prices, QIPT is priced at $2.31, while NNOX trades at $4.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QIPT currently has a P/E ratio of -11.00, whereas NNOX's P/E ratio is -5.05. In terms of profitability, QIPT's ROE is -0.08%, compared to NNOX's ROE of -0.31%. Regarding short-term risk, QIPT is more volatile compared to NNOX. This indicates potentially higher risk in terms of short-term price fluctuations for QIPT.Check NNOX's competition here
QIPT vs CLPT Comparison August 2025
QIPT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QIPT stands at 100.4M. In comparison, CLPT has a market cap of 282.7M. Regarding current trading prices, QIPT is priced at $2.31, while CLPT trades at $10.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QIPT currently has a P/E ratio of -11.00, whereas CLPT's P/E ratio is -13.16. In terms of profitability, QIPT's ROE is -0.08%, compared to CLPT's ROE of -0.78%. Regarding short-term risk, QIPT is more volatile compared to CLPT. This indicates potentially higher risk in terms of short-term price fluctuations for QIPT.Check CLPT's competition here
QIPT vs QTRX Comparison August 2025
QIPT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QIPT stands at 100.4M. In comparison, QTRX has a market cap of 273.4M. Regarding current trading prices, QIPT is priced at $2.31, while QTRX trades at $5.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QIPT currently has a P/E ratio of -11.00, whereas QTRX's P/E ratio is -4.73. In terms of profitability, QIPT's ROE is -0.08%, compared to QTRX's ROE of -0.15%. Regarding short-term risk, QIPT is more volatile compared to QTRX. This indicates potentially higher risk in terms of short-term price fluctuations for QIPT.Check QTRX's competition here
QIPT vs CATX Comparison August 2025
QIPT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QIPT stands at 100.4M. In comparison, CATX has a market cap of 272.4M. Regarding current trading prices, QIPT is priced at $2.31, while CATX trades at $3.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QIPT currently has a P/E ratio of -11.00, whereas CATX's P/E ratio is -2.98. In terms of profitability, QIPT's ROE is -0.08%, compared to CATX's ROE of -0.27%. Regarding short-term risk, QIPT is more volatile compared to CATX. This indicates potentially higher risk in terms of short-term price fluctuations for QIPT.Check CATX's competition here
QIPT vs OM Comparison August 2025
QIPT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QIPT stands at 100.4M. In comparison, OM has a market cap of 266.5M. Regarding current trading prices, QIPT is priced at $2.31, while OM trades at $15.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QIPT currently has a P/E ratio of -11.00, whereas OM's P/E ratio is -0.52. In terms of profitability, QIPT's ROE is -0.08%, compared to OM's ROE of -1.45%. Regarding short-term risk, QIPT is more volatile compared to OM. This indicates potentially higher risk in terms of short-term price fluctuations for QIPT.Check OM's competition here
QIPT vs BFLY-WT Comparison August 2025
QIPT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QIPT stands at 100.4M. In comparison, BFLY-WT has a market cap of 249.1M. Regarding current trading prices, QIPT is priced at $2.31, while BFLY-WT trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QIPT currently has a P/E ratio of -11.00, whereas BFLY-WT's P/E ratio is N/A. In terms of profitability, QIPT's ROE is -0.08%, compared to BFLY-WT's ROE of -0.31%. Regarding short-term risk, QIPT is less volatile compared to BFLY-WT. This indicates potentially lower risk in terms of short-term price fluctuations for QIPT.Check BFLY-WT's competition here
QIPT vs CERS Comparison August 2025
QIPT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QIPT stands at 100.4M. In comparison, CERS has a market cap of 239.9M. Regarding current trading prices, QIPT is priced at $2.31, while CERS trades at $1.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QIPT currently has a P/E ratio of -11.00, whereas CERS's P/E ratio is -12.55. In terms of profitability, QIPT's ROE is -0.08%, compared to CERS's ROE of -0.35%. Regarding short-term risk, QIPT is more volatile compared to CERS. This indicates potentially higher risk in terms of short-term price fluctuations for QIPT.Check CERS's competition here
QIPT vs VMD Comparison August 2025
QIPT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QIPT stands at 100.4M. In comparison, VMD has a market cap of 234.4M. Regarding current trading prices, QIPT is priced at $2.31, while VMD trades at $5.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QIPT currently has a P/E ratio of -11.00, whereas VMD's P/E ratio is 19.77. In terms of profitability, QIPT's ROE is -0.08%, compared to VMD's ROE of +0.10%. Regarding short-term risk, QIPT is more volatile compared to VMD. This indicates potentially higher risk in terms of short-term price fluctuations for QIPT.Check VMD's competition here
QIPT vs MASS Comparison August 2025
QIPT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QIPT stands at 100.4M. In comparison, MASS has a market cap of 230.2M. Regarding current trading prices, QIPT is priced at $2.31, while MASS trades at $6.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QIPT currently has a P/E ratio of -11.00, whereas MASS's P/E ratio is -2.89. In terms of profitability, QIPT's ROE is -0.08%, compared to MASS's ROE of -0.13%. Regarding short-term risk, QIPT is more volatile compared to MASS. This indicates potentially higher risk in terms of short-term price fluctuations for QIPT.Check MASS's competition here
QIPT vs TCMD Comparison August 2025
QIPT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QIPT stands at 100.4M. In comparison, TCMD has a market cap of 224.3M. Regarding current trading prices, QIPT is priced at $2.31, while TCMD trades at $9.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QIPT currently has a P/E ratio of -11.00, whereas TCMD's P/E ratio is 14.62. In terms of profitability, QIPT's ROE is -0.08%, compared to TCMD's ROE of +0.08%. Regarding short-term risk, QIPT is more volatile compared to TCMD. This indicates potentially higher risk in terms of short-term price fluctuations for QIPT.Check TCMD's competition here
QIPT vs NVRO Comparison August 2025
QIPT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QIPT stands at 100.4M. In comparison, NVRO has a market cap of 224.1M. Regarding current trading prices, QIPT is priced at $2.31, while NVRO trades at $5.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QIPT currently has a P/E ratio of -11.00, whereas NVRO's P/E ratio is -1.91. In terms of profitability, QIPT's ROE is -0.08%, compared to NVRO's ROE of -0.43%. Regarding short-term risk, QIPT is more volatile compared to NVRO. This indicates potentially higher risk in terms of short-term price fluctuations for QIPT.Check NVRO's competition here
QIPT vs MXCT Comparison August 2025
QIPT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QIPT stands at 100.4M. In comparison, MXCT has a market cap of 216.9M. Regarding current trading prices, QIPT is priced at $2.31, while MXCT trades at $2.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QIPT currently has a P/E ratio of -11.00, whereas MXCT's P/E ratio is -5.10. In terms of profitability, QIPT's ROE is -0.08%, compared to MXCT's ROE of -0.20%. Regarding short-term risk, QIPT is more volatile compared to MXCT. This indicates potentially higher risk in terms of short-term price fluctuations for QIPT.Check MXCT's competition here
QIPT vs BWAY Comparison August 2025
QIPT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QIPT stands at 100.4M. In comparison, BWAY has a market cap of 216.8M. Regarding current trading prices, QIPT is priced at $2.31, while BWAY trades at $11.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QIPT currently has a P/E ratio of -11.00, whereas BWAY's P/E ratio is 52.14. In terms of profitability, QIPT's ROE is -0.08%, compared to BWAY's ROE of +0.07%. Regarding short-term risk, QIPT is more volatile compared to BWAY. This indicates potentially higher risk in terms of short-term price fluctuations for QIPT.Check BWAY's competition here
QIPT vs EYES Comparison August 2025
QIPT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QIPT stands at 100.4M. In comparison, EYES has a market cap of 210M. Regarding current trading prices, QIPT is priced at $2.31, while EYES trades at $4.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QIPT currently has a P/E ratio of -11.00, whereas EYES's P/E ratio is N/A. In terms of profitability, QIPT's ROE is -0.08%, compared to EYES's ROE of -0.26%. Regarding short-term risk, QIPT is more volatile compared to EYES. This indicates potentially higher risk in terms of short-term price fluctuations for QIPT.Check EYES's competition here
QIPT vs CVRX Comparison August 2025
QIPT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QIPT stands at 100.4M. In comparison, CVRX has a market cap of 197.1M. Regarding current trading prices, QIPT is priced at $2.31, while CVRX trades at $7.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QIPT currently has a P/E ratio of -11.00, whereas CVRX's P/E ratio is -3.53. In terms of profitability, QIPT's ROE is -0.08%, compared to CVRX's ROE of -0.79%. Regarding short-term risk, QIPT is more volatile compared to CVRX. This indicates potentially higher risk in terms of short-term price fluctuations for QIPT.Check CVRX's competition here
QIPT vs MGRM Comparison August 2025
QIPT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QIPT stands at 100.4M. In comparison, MGRM has a market cap of 194.9M. Regarding current trading prices, QIPT is priced at $2.31, while MGRM trades at $5.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QIPT currently has a P/E ratio of -11.00, whereas MGRM's P/E ratio is -10.78. In terms of profitability, QIPT's ROE is -0.08%, compared to MGRM's ROE of -1.26%. Regarding short-term risk, QIPT is more volatile compared to MGRM. This indicates potentially higher risk in terms of short-term price fluctuations for QIPT.Check MGRM's competition here
QIPT vs SGHT Comparison August 2025
QIPT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QIPT stands at 100.4M. In comparison, SGHT has a market cap of 169.1M. Regarding current trading prices, QIPT is priced at $2.31, while SGHT trades at $3.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QIPT currently has a P/E ratio of -11.00, whereas SGHT's P/E ratio is -3.34. In terms of profitability, QIPT's ROE is -0.08%, compared to SGHT's ROE of -0.55%. Regarding short-term risk, QIPT is more volatile compared to SGHT. This indicates potentially higher risk in terms of short-term price fluctuations for QIPT.Check SGHT's competition here
QIPT vs INGN Comparison August 2025
QIPT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QIPT stands at 100.4M. In comparison, INGN has a market cap of 167M. Regarding current trading prices, QIPT is priced at $2.31, while INGN trades at $6.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QIPT currently has a P/E ratio of -11.00, whereas INGN's P/E ratio is -5.40. In terms of profitability, QIPT's ROE is -0.08%, compared to INGN's ROE of -0.15%. Regarding short-term risk, QIPT is more volatile compared to INGN. This indicates potentially higher risk in terms of short-term price fluctuations for QIPT.Check INGN's competition here
QIPT vs PROF Comparison August 2025
QIPT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QIPT stands at 100.4M. In comparison, PROF has a market cap of 165.3M. Regarding current trading prices, QIPT is priced at $2.31, while PROF trades at $5.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QIPT currently has a P/E ratio of -11.00, whereas PROF's P/E ratio is -4.55. In terms of profitability, QIPT's ROE is -0.08%, compared to PROF's ROE of -0.70%. Regarding short-term risk, QIPT is more volatile compared to PROF. This indicates potentially higher risk in terms of short-term price fluctuations for QIPT.Check PROF's competition here
QIPT vs TLSI Comparison August 2025
QIPT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QIPT stands at 100.4M. In comparison, TLSI has a market cap of 158.7M. Regarding current trading prices, QIPT is priced at $2.31, while TLSI trades at $4.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QIPT currently has a P/E ratio of -11.00, whereas TLSI's P/E ratio is -3.80. In terms of profitability, QIPT's ROE is -0.08%, compared to TLSI's ROE of +1.04%. Regarding short-term risk, QIPT is more volatile compared to TLSI. This indicates potentially higher risk in terms of short-term price fluctuations for QIPT.Check TLSI's competition here
QIPT vs ELMD Comparison August 2025
QIPT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QIPT stands at 100.4M. In comparison, ELMD has a market cap of 151.7M. Regarding current trading prices, QIPT is priced at $2.31, while ELMD trades at $18.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QIPT currently has a P/E ratio of -11.00, whereas ELMD's P/E ratio is 22.90. In terms of profitability, QIPT's ROE is -0.08%, compared to ELMD's ROE of +0.17%. Regarding short-term risk, QIPT is more volatile compared to ELMD. This indicates potentially higher risk in terms of short-term price fluctuations for QIPT.Check ELMD's competition here
QIPT vs LNSR Comparison August 2025
QIPT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QIPT stands at 100.4M. In comparison, LNSR has a market cap of 150.1M. Regarding current trading prices, QIPT is priced at $2.31, while LNSR trades at $12.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QIPT currently has a P/E ratio of -11.00, whereas LNSR's P/E ratio is -2.59. In terms of profitability, QIPT's ROE is -0.08%, compared to LNSR's ROE of -5.28%. Regarding short-term risk, QIPT is more volatile compared to LNSR. This indicates potentially higher risk in terms of short-term price fluctuations for QIPT.Check LNSR's competition here
QIPT vs RPID Comparison August 2025
QIPT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QIPT stands at 100.4M. In comparison, RPID has a market cap of 145.1M. Regarding current trading prices, QIPT is priced at $2.31, while RPID trades at $3.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QIPT currently has a P/E ratio of -11.00, whereas RPID's P/E ratio is -3.21. In terms of profitability, QIPT's ROE is -0.08%, compared to RPID's ROE of -0.56%. Regarding short-term risk, QIPT is less volatile compared to RPID. This indicates potentially lower risk in terms of short-term price fluctuations for QIPT.Check RPID's competition here
QIPT vs RCEL Comparison August 2025
QIPT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QIPT stands at 100.4M. In comparison, RCEL has a market cap of 136.4M. Regarding current trading prices, QIPT is priced at $2.31, while RCEL trades at $5.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QIPT currently has a P/E ratio of -11.00, whereas RCEL's P/E ratio is -2.36. In terms of profitability, QIPT's ROE is -0.08%, compared to RCEL's ROE of -3.38%. Regarding short-term risk, QIPT is more volatile compared to RCEL. This indicates potentially higher risk in terms of short-term price fluctuations for QIPT.Check RCEL's competition here
QIPT vs BSGM Comparison August 2025
QIPT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QIPT stands at 100.4M. In comparison, BSGM has a market cap of 134.4M. Regarding current trading prices, QIPT is priced at $2.31, while BSGM trades at $4.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QIPT currently has a P/E ratio of -11.00, whereas BSGM's P/E ratio is -8.09. In terms of profitability, QIPT's ROE is -0.08%, compared to BSGM's ROE of -35.30%. Regarding short-term risk, QIPT is less volatile compared to BSGM. This indicates potentially lower risk in terms of short-term price fluctuations for QIPT.Check BSGM's competition here
QIPT vs ANIK Comparison August 2025
QIPT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QIPT stands at 100.4M. In comparison, ANIK has a market cap of 124.6M. Regarding current trading prices, QIPT is priced at $2.31, while ANIK trades at $8.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QIPT currently has a P/E ratio of -11.00, whereas ANIK's P/E ratio is -9.60. In terms of profitability, QIPT's ROE is -0.08%, compared to ANIK's ROE of -0.35%. Regarding short-term risk, QIPT is more volatile compared to ANIK. This indicates potentially higher risk in terms of short-term price fluctuations for QIPT.Check ANIK's competition here
QIPT vs OWLT Comparison August 2025
QIPT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QIPT stands at 100.4M. In comparison, OWLT has a market cap of 122.1M. Regarding current trading prices, QIPT is priced at $2.31, while OWLT trades at $7.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QIPT currently has a P/E ratio of -11.00, whereas OWLT's P/E ratio is -4.59. In terms of profitability, QIPT's ROE is -0.08%, compared to OWLT's ROE of +1.25%. Regarding short-term risk, QIPT is more volatile compared to OWLT. This indicates potentially higher risk in terms of short-term price fluctuations for QIPT.Check OWLT's competition here
QIPT vs AVR Comparison August 2025
QIPT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QIPT stands at 100.4M. In comparison, AVR has a market cap of 114.5M. Regarding current trading prices, QIPT is priced at $2.31, while AVR trades at $3.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QIPT currently has a P/E ratio of -11.00, whereas AVR's P/E ratio is -0.88. In terms of profitability, QIPT's ROE is -0.08%, compared to AVR's ROE of -2.92%. Regarding short-term risk, QIPT is more volatile compared to AVR. This indicates potentially higher risk in terms of short-term price fluctuations for QIPT.Check AVR's competition here
QIPT vs LUCD Comparison August 2025
QIPT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QIPT stands at 100.4M. In comparison, LUCD has a market cap of 108.2M. Regarding current trading prices, QIPT is priced at $2.31, while LUCD trades at $1.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QIPT currently has a P/E ratio of -11.00, whereas LUCD's P/E ratio is -0.85. In terms of profitability, QIPT's ROE is -0.08%, compared to LUCD's ROE of +26.96%. Regarding short-term risk, QIPT is more volatile compared to LUCD. This indicates potentially higher risk in terms of short-term price fluctuations for QIPT.Check LUCD's competition here
QIPT vs ICAD Comparison August 2025
QIPT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QIPT stands at 100.4M. In comparison, ICAD has a market cap of 106.3M. Regarding current trading prices, QIPT is priced at $2.31, while ICAD trades at $3.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QIPT currently has a P/E ratio of -11.00, whereas ICAD's P/E ratio is -20.37. In terms of profitability, QIPT's ROE is -0.08%, compared to ICAD's ROE of -0.17%. Regarding short-term risk, QIPT is more volatile compared to ICAD. This indicates potentially higher risk in terms of short-term price fluctuations for QIPT.Check ICAD's competition here
QIPT vs HJLI Comparison August 2025
QIPT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QIPT stands at 100.4M. In comparison, HJLI has a market cap of 98.3M. Regarding current trading prices, QIPT is priced at $2.31, while HJLI trades at $10.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QIPT currently has a P/E ratio of -11.00, whereas HJLI's P/E ratio is N/A. In terms of profitability, QIPT's ROE is -0.08%, compared to HJLI's ROE of -0.57%. Regarding short-term risk, QIPT is more volatile compared to HJLI. This indicates potentially higher risk in terms of short-term price fluctuations for QIPT.Check HJLI's competition here
QIPT vs FONR Comparison August 2025
QIPT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QIPT stands at 100.4M. In comparison, FONR has a market cap of 97M. Regarding current trading prices, QIPT is priced at $2.31, while FONR trades at $15.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QIPT currently has a P/E ratio of -11.00, whereas FONR's P/E ratio is 12.51. In terms of profitability, QIPT's ROE is -0.08%, compared to FONR's ROE of +0.09%. Regarding short-term risk, QIPT is more volatile compared to FONR. This indicates potentially higher risk in terms of short-term price fluctuations for QIPT.Check FONR's competition here
QIPT vs ASXC Comparison August 2025
QIPT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QIPT stands at 100.4M. In comparison, ASXC has a market cap of 94.9M. Regarding current trading prices, QIPT is priced at $2.31, while ASXC trades at $0.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QIPT currently has a P/E ratio of -11.00, whereas ASXC's P/E ratio is -1.12. In terms of profitability, QIPT's ROE is -0.08%, compared to ASXC's ROE of -5.59%. Regarding short-term risk, QIPT is more volatile compared to ASXC. This indicates potentially higher risk in terms of short-term price fluctuations for QIPT.Check ASXC's competition here